Related Articles
Antitumor efficacy of sequential treatment with docetaxel and 5-fluorouracil against human oral cancer cells
FOXM1 is a novel predictor of recurrence in patients with oral squamous cell carcinoma associated with an increase in epithelial‑mesenchymal transition
Ribonucleotide reductase M2 is a promising molecular target for the treatment of oral squamous cell carcinoma
FoxM1 overexpression promotes cell proliferation and migration and inhibits apoptosis in hypopharyngeal squamous cell carcinoma resulting in poor clinical prognosis
Combined overexpression of cadherin 6, cadherin 11 and cluster of differentiation 44 is associated with lymph node metastasis and poor prognosis in oral squamous cell carcinoma